Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries
Author:
Funder
Zorginstituut Nederland
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/27/9/1768/16698123/mdw233.pdf
Reference20 articles.
1. Valuing end-of-life care in the United States: the case of new cancer drugs;Sorensen;Health Econ Pol Law,2012
2. Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison;Sorenson;Issue Brief (Commonw Fund),2010
3. Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions;Kleijnen;Value Health,2012
4. Can a joint assessment provide relevant information for national/local relative effectiveness assessments? An in-depth comparison of pazopanib assessments;Kleijnen;Value Health,2015
5. A review of health technology appraisals: case studies in oncology;Shah;Int J Technol Assess Health Care,2013
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Reporting reimbursement price decisions for onco-hematology drugs in Spain;Frontiers in Public Health;2023-10-24
2. Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies — can alignment be improved?;Expert Review of Pharmacoeconomics & Outcomes Research;2023-09-28
3. Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe;Health Policy and Technology;2023-09
4. Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis;International Journal of Technology Assessment in Health Care;2023
5. The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries’ past health technology assessments;International Journal of Technology Assessment in Health Care;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3